Cell Signaling Technology

Product Pathways - Cytoskeletal Signaling

VASP (A290) Antibody #3120

Applications Reactivity MW (kDa) Source
W H Mk 46, 50 Rabbit

Applications Key:  W=Western Blotting
Reactivity Key:  H=Human  Mk=Monkey
Species enclosed in parentheses are predicted to react based on 100% sequence homology. Species cross-reactivity is determined by Western blot.

Specificity / Sensitivity

VASP (A290) Antibody detects endogenous levels of total VASP protein.

Source / Purification

Polyclonal antibodies are produced by immunizing rabbits with a synthetic peptide (KLH-coupled) corresponding the carboxy-terminal sequence of human VASP. Antibodies are purified by peptide affinity chromatography.

Western Blotting

Western Blotting

Western blot analysis of extracts from various cell types, using VASP (A290) Antibody.

Western Blotting

Western Blotting

Western blot analysis of extracts from HeLa cells, untreated or forskolin-treated (10 µM, 15 minutes), using VASP (A290) Antibody.

Background

Vasodilator-stimulated phosphoprotein (VASP) was originally characterized as a substrate of both cGMP- and cAMP-dependent kinases (PKG and PKA, or cGPK and cAPK, respectively) (1). It is now believed that VASP belongs to the Ena/VASP family of adaptor proteins linking the cytoskeletal system to the signal transduction pathways and that it functions in cytoskeletal organization, fibroblast migration, platelet activation and axon guidance (2,3). Three phosphorylation sites, Ser157, Ser239 and Thr278, have been identified. Ser239 is the major PKG phosphorylation site while Ser157 is the major PKA phosphorylation site (4). Evidence suggests that VASP phosphorylation reduces its association with actin and has a negative effect on actin polymerization (5). Phosphorylation at Ser239 of VASP is a useful marker for monitoring PKG activation and signaling (6,7).

  1. Butt, E. et al. (1994) J. Biol. Chem. 269, 14509-14517.
  2. Ball, L.J. et al. (2000) EMBO J. 19, 4903-4914.
  3. Machesky, L.M. et al. (2000) Cell 101, 685-688.
  4. Smolenski, A. et al. (1998) J. Biol. Chem. 273, 20029-20035.
  5. Harbeck, B. et al. (2000) J. Biol. Chem. 275, 30817-30825.
  6. Oelze, M. et al. (2000) Circ. Res. 87, 999-1005.
  7. Lawrence, D.W. et al. (2001) J. Immunol. 166, 5550-5556.

Application References

Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!

Companion Products

Product Pathways

Drug Discovery Tools

Featured Technologies

Protein Classes